A US subsidiary of Laurus Labs, Laurus Generics Inc. is a vertically integrated pharmaceutical company. We combine deep process chemistry expertise with manufacturing excellence to develop and manufacture innovative medicines. Our formulation portfolio is backed by in-house APIs covering HIV, Diabetes, CVS and CNS therapy areas. Located in India, our state-of-the-art R&D and manufacturing operations are approved by global regulatory authorities. Our manufacturing site, in Visakhapatnam, India, has an installed capacity of 5 billion tablets with scope for further expansion. With customers in 56 countries around the world, we are improved health outcomes for millions of patients.


Our research-first approach has been critical to our success and it continues to be a clear differentiator. We undertake dedicated R&D in critical disease areas to develop medicines with a twin focus on quality and affordability.

NDC Product Name Strength Pack Size(s) Therapy Area Brand Reference Prescribing Info MSDS Front Image Back Image
42385-904-10 Metformin 500 mg 1000 Anti-diabetic Glucophage
42385-903-10 Metformin 1000 mg 1000 Anti-diabetic Glucophage
42385-929-31 Efavirenz + Lamivudine +
Tenofovir Disoproxil Fumarate
400/300/300 Mg 30 Antiretroviral SYMFI LO
42385-928-30 Efavirenz + Lamivudine +
Tenofovir Disoproxil Fumarate
600/300/300 Mg 30 Antiretroviral SYMFI
42385-935-90 Fenofibrate 54 mg 90 Antilipemic Tricor
42385-936-90 Fenofibrate 160 mg 90 Antilipemic Tricor
42385-936-05 Fenofibrate 160 mg 500 Antilipemic Tricor
42385-944-90 Fenofibric Acid Delayed-Release Capsules 45 mg 90 Antihyperlipidemic TRILIPIX
42385-945-90 Fenofibric Acid Delayed-Release Capsules 135 mg 90 Antihyperlipidemic TRILIPIX


Adverse event reporting

Email: info.generics@lauruslabs.com

Tel: 833-3LAURUS

Customer service

Email: lauruslabsCS@icsconnect.com

Tel: 833-3LAURUS


400 Connell Drive, Suite 5200
Berkeley Heights, NJ 07922

© 2019 Laurus Labs. All Rights Reserved